Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCV Screening and Treatment in County Jails
NCT06533319Not yet recruiting
- Sponsor
- Eastern Idaho Public Health
- Start
- Aug 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of sofosbuvir + velpatasvir in hepatitis C virus infection, sponsored by Eastern Idaho Public Health. Primary endpoint: Sustained Virologic Response. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
sofosbuvir + velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT06533319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06533319.